Interview with Daphné Lecomte-Somaggio, Director General, AFIPA –…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
Shire serves as an industry leader in research and treatments of rare and orphan diseases, allowing patients with severe conditions to lead better lives. The company’s deep understanding of patients and their needs enables them to develop and deliver health care in therapeutic areas including, behavioral disorders and gastrointestinal diseases, as well as other symptomatic conditions followed by specialists. Shire upholds an ambition to imagine the future and be at the forefront of health care in creating value for patients, physicians, policymakers, payers and shareholders. Shire France is the French subsidiary of Shire Pharmaceuticals Group plc based in the UK and the US. As the operator of specialty pharmaceuticals and as such, its products are sold by the conventional circuit of distribution: custodians, distributors, pharmaceutical wholesale distributors, pharmacies, care facilities. The French affiliate specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, genetic diseases.
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FPS is a hundred year old organization with roots in the beginning of the last century representing today SME suppliers to the health industries. Given the variety of its membership…
US pharmaceutical companies have long been in the French market but in your experience how do you feel they have integrated the differences in culture? Is this a finished topic…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French one. Today the gap…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent has France kept up?…
France is a major pharmaceutical market, leader in Europe and number three in the world but it seems in biotechnologies, France lags behind. In your opinion, what has caused this?…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as much as possible activities…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical sector. To what degree…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half…
See our Cookie Privacy Policy Here
